A comprehensive single cell data analysis of in lymphoblastoid cells reveals the role of Super-enhancers in maintaining EBV latency

Bingyu Yan, Chong Wang, Srishti Chakravorty, Zonghao Zhang, Simran D. Kadadi, Yuxin Zhuang, Isabella Sirit, Yonghua Hu, Minwoo Jung, Subhransu S. Sahoo, Luopin Wang, Kunming Shao, Nicole Anderson, Jorge L. Trujillo‐Ochoa, Xing Liu, Matthew R. Olson, Behdad Afzali, Bo Zhao, Majid KazemianbioRxiv 2022 · DOI

TL;DR

This study uses single-cell RNA sequencing to reveal significant heterogeneity in Epstein-Barr Virus (EBV) infected cells, identifying distinct populations based on viral gene expression. They discovered that super-enhancers (SEs) play a crucial role in maintaining EBV latency, and disrupting these SEs can trigger EBV's lytic replication.

What Problem Does This Paper Address?

Epstein-Barr Virus (EBV) is a common human herpesvirus that establishes a lifelong latent infection, primarily in B cells. While most infected cells remain in a latent state, a small fraction can spontaneously enter a lytic phase to produce new virus. Understanding the cellular programs that govern this switch between latent and lytic states, and the heterogeneity within these populations, has been challenging. Traditional bulk RNA sequencing methods can obscure these finer details. This paper aims to dissect the complex interplay between EBV and its host cells at a single-cell level, specifically investigating the role of host regulatory elements like super-enhancers in controlling EBV's life cycle.

Methods

The researchers employed single-cell RNA sequencing (scRNA-seq) on publicly available datasets from nine lymphoblastoid cell lines (LCLs). They used the Seurat platform for data integration, normalization, and unsupervised clustering to identify distinct cell populations based on both host and viral gene expression. To investigate the functional roles of identified genes and pathways, they utilized Gene Set Enrichment Analysis (GSEA). To experimentally validate their findings regarding super-enhancers, they employed CRISPR-mediated gene editing (CRISPRi and dual sgRNA deletion) to disrupt specific super-enhancer regions and then assessed the impact on EBV lytic gene expression using qRT-PCR and flow cytometry.

Datasets

The study utilized publicly available single-cell RNA sequencing data from nine lymphoblastoid cell lines (LCLs). Specific datasets are referenced by their GEO accession numbers (e.g., GSE126321, GSE111912, etc.). They also used ChIP-seq data for various transcription factors and histone modifications (e.g., EBNA2, H3K27ac) from the GM12878 cell line.

Key Insights and Ideas

  • EBV-infected cells are not a uniform population: The scRNA-seq analysis revealed distinct subpopulations within LCLs, differing significantly in their EBV gene expression profiles, suggesting different stages of the EBV life cycle are active simultaneously.
  • Super-enhancers are critical for EBV latency: The study identified a novel role for host super-enhancers (SEs) in maintaining EBV's latent state. Disrupting these SEs, particularly those associated with genes like MYC and IRF4, triggered EBV lytic reactivation.
  • HIF1-α signaling is linked to a specific EBV-infected cell state: One of the identified clusters, characterized by high LMP1 expression but low GP350, showed a strong HIF1-α signature. This pathway could be therapeutically targeted to influence this specific cell state.
  • Lytic EBV replication disrupts host gene expression programs: Cells in the lytic phase exhibited significantly lower expression of genes regulated by SEs, suggesting a broader impact on host cell transcriptional machinery during active viral replication.

Key Results

  • The analysis identified three major clusters of LCLs based on EBV gene expression, representing latent, early lytic, and fully lytic states.
  • Cells in the GP350-LMP1hi cluster showed a distinct HIF1-α-associated signature, and treatment with the HIF1-α stabilizer Pevonedistat induced expression of HIF1A, LMP1, and PDL1.
  • Super-enhancer-regulated genes were found to be less highly expressed in the GP350+LMP1hi lytic cluster compared to latent cells.
  • CRISPR-mediated disruption of MYC and IRF4 SEs in LCLs led to increased expression of EBV lytic genes, demonstrating a causal link between SE function and EBV latency.
  • Experimental induction of EBV lytic reactivation in AKATA cells led to repression of MYC and IKZF3, genes regulated by SEs.

Limitations and Future Work

  • The study acknowledges the challenge of quantifying EBV genome expression due to overlapping genes like LMP1 and BNLF2a/b, which could be exacerbated by 3' mRNA capture bias in some single-cell technologies.
  • While the study demonstrates that disrupting SEs induces EBV lytic reactivation, the precise mechanisms by which SEs maintain latency require further investigation.
  • The authors suggest that further studies are needed to fully discern the observation that lytic reactivation after SE disruption occurred prior to IRF4 downregulation, implying SEs themselves might be necessary for latency maintenance.
  • The role of PRDM1 in EBV lytic reactivation needs further clarification, as its expression was found to be lower in lytic cells in this study, contrasting with previous reports. Future work could explore whether PRDM1 is important for initiation rather than maintenance of the lytic cycle, or if only its transcription factor activity, not overall expression, is crucial.
  • The potential for drugs that stabilize HIF1-α to inadvertently induce LMP1 in diseases associated with EBV type III latency programs warrants further investigation.

Summary updated

Abstract

Abstract We probed the lifecycle of EBV on a cell-by-cell basis using single cell RNA sequencing (scRNA-seq) data from nine publicly available lymphoblastoid cell lines (LCL). While the majority of LCLs comprised cells containing EBV in the latent phase, two other clusters of cells were clearly evident and were distinguished by distinct expression of host and viral genes. Notably, both were high expressors of EBV LMP1 / BNLF2 and BZLF1 compared to another cluster that expressed neither gene. The two novel clusters differed from each other in their expression of EBV lytic genes, including glycoprotein gene GP350 . The first cluster, comprising GP350 − LMP1 hi cells, expressed high levels of HIF1A and was transcriptionally regulated by HIF1-α. Treatment of LCLs with Pevonedistat, a drug that enhances HIF1-α signaling, markedly induced this cluster. The second cluster, containing GP350 + LMP1 hi cells, expressed EBV lytic genes. Host genes that are controlled by super-enhancers (SEs), such as transcription factors MYC and IRF4 , had the lowest expression in this cluster. Functionally, the expression of genes regulated by MYC and IRF4 in GP350 + LMP1 hi cells were lower compared to other cells. Indeed, induction of EBV lytic reactivation in EBV + AKATA reduced the expression of these SE-regulated genes. Furthermore, CRISPR-mediated perturbation of the MYC or IRF4 SEs in LCLs induced the lytic EBV gene expression, suggesting that host SEs and/or SE target genes are required for maintenance of EBV latency. Collectively, our study revealed EBV associated heterogeneity among LCLs that may have functional consequence on host and viral biology. Importance Epstein-Barr virus (EBV) establishes a life-long latency program within host cells. As such, EBV immortalized lymphoblastoid cells (LCLs) often carry the latent EBV genome and only a small percentage of LCLs containing lytic EBV. However, the cellular programs that distinguish latent from lytic cells and the heterogeneity of cells in latent or lytic phases remains poorly explored. To explore these unknowns, we reanalyzed publicly available single cell RNA-seq data from nine LCLs. This approach permitted the simultaneous study of cells in both latent and lytic phases. We identified three cell populations with distinct lytic/latent activity and further characterized the transcriptomes of these cells. We also identified a new role of super-enhancers in regulating EBV lytic replication. Collectively, our studies revealed EBV associated heterogeneity among LCLs that contribute to EBV life cycle and biology.
BibTeX
@misc{yan2022comprehensive,
  author = {Bingyu Yan and Chong Wang and Srishti Chakravorty and Zonghao Zhang and Simran D. Kadadi and Yuxin Zhuang and Isabella Sirit and Yonghua Hu and Minwoo Jung and Subhransu S. Sahoo and Luopin Wang and Kunming Shao and Nicole Anderson and Jorge L. Trujillo‐Ochoa and Xing Liu and Matthew R. Olson and Behdad Afzali and Bo Zhao and Majid Kazemian},
  title = {{A comprehensive single cell data analysis of in lymphoblastoid cells reveals the role of Super-enhancers in maintaining EBV latency}},
  year = {2022},
  doi = {10.1101/2022.08.10.503552},
  howpublished = {bioRxiv},
}
Figure